Kunobufakazi obusha bokuthi i-antibody ye-COVID-19 yokutheleleka kwangaphambilini izonciphisa kakhulu ingcuphe yokutheleleka kabusha ngokuzayo.
Ucwaningo olushicilelwe ngoLwesithathu ephephabhukwini i-JAMA Internal Medicine lithole ukuthi abantu abahlolelwe i-COVID-19 banengozi encishisiwe yokutheleleka nge-coronavirus uma kuqhathaniswa nalabo abahlolelwa ukuthi abanawo amasosha omzimba.
UDkt. Douglas Lowy wathi: “Imiphumela yalolu cwaningo ngokuyisisekelo yehliswe ngenani le-10, kodwa nginezixwayiso mayelana nalokhu.Ngamanye amazwi, lokhu kungase kube ukucabangela ngokweqile kokunciphisa.Lokhu kungase kube yiqiniso.Ukubukelwa phansi kokuncipha.”ungumbhali wocwaningo kanye nesekela lomqondisi weNational Cancer Institute.
Uthe: “Kimina, umyalezo omkhulu uncishisiwe."Okubalulekile ukuthi amasosha omzimba anamandla ngemuva kokutheleleka kwemvelo ahlobene nokuvimbela izifo ezintsha."
U-Lowy wengeze ngokuthi abantu abeluleme ku-COVID-19 kusafanele bagonywe uma sekuyithuba labo.
Abacwaningi abavela ku-National Cancer Institute kanye nezinkampani ezifana ne-LabCorp, Quest Diagnostics, Aetion Inc. kanye ne-HealthVerity bafunde idatha yabantu abangaphezu kwezigidi ezingu-3.2 e-United States abaphothule ukuhlolwa kwe-COVID-19 phakathi kukaJanuwari no-Agasti ngonyaka odlule.Kulezi zivivinyo, ama-11.6% amasosha omzimba e-COVID-19 ayenayo kanti angama-88.3% ayengenayo.
Emininingwaneni yokulandelela, abacwaningi bathola ukuthi ngemuva kwezinsuku ezingama-90, bangu-0.3% kuphela abantu abahlolelwe ukuthi bane-COVID-19 amasosha agcina etholakele ukuthi bane-coronavirus.Phakathi kweziguli ezinemiphumela yokuhlolwa kwe-COVID-19 engemihle, ama-3% kamuva atholakala enegciwane le-coronavirus ngesikhathi esifanayo.
Sekukonke, lolu cwaningo luyaqaphelisisa, futhi lubonisa ukuhlobana phakathi komphumela wokuhlolwa kwamasosha omzimba we-COVID-19 kanye nengozi encishisiwe yokutheleleka ngemva kwezinsuku ezingama-90-kodwa ucwaningo olwengeziwe luyadingeka ukuze kutholwe imbangela kanye nokuthi i-antibody ivikelwa isikhathi esingakanani Okokugcina.
URoy uthe ucwaningo olwengeziwe luyadingeka ukuze kutholwe ubungozi bokutheleleka kabusha okubangelwa enye yezinhlobo ezivelayo ze-coronavirus.
ULowe uthe: “Manje kukhona lokhu kukhathazeka.Asho ukuthini?Impendulo emfushane ukuthi asazi.”Uphinde wagcizelela ukuthi abantu abahlolelwa ukuthi banamasosha omzimba kusafanele bagonyelwe i-COVID-19.
Kuyaziwa ukuthi iningi leziguli ezilulama ku-COVID-19 linamasosha omzimba, futhi kuze kube manje, ukuphinda kutheleleke ngegciwane kubonakala kuyivelakancane-kodwa "kuyohlala isikhathi esingakanani ukuvikelwa kwe-antibody ngenxa yezifo zemvelo" akukacaci," uDkt Mitchell Katz we-NYC Health + Uhlelo lokunakekelwa kwezempilo lwesibhedlela lwabhala esihlokweni esashicilelwa kanye nocwaningo olusha lwe-JAMA Internal Medicine.
UKatz wabhala: “Ngakho-ke, kungakhathalekile ukuthi isiphi isimo se-antibody, kuyanconywa ukuthi uthole umuthi wokugomela i-SARS-CoV-2.”I-SARS-CoV-2 yigama le-coronavirus ebangela i-COVID-19.
Wabhala: “Isikhathi sokuvikelwa kwamasosha omzimba esinikezwa ngemijovo asaziwa.”“Kubalulekile ukwazi ukuthi ukuvikelwa kwamasosha omzimba kuthatha isikhathi esingakanani ngenxa yokutheleleka kwemvelo noma ukugoma.Isikhathi kuphela esizosho. ”
I-Hearst Television ibamba iqhaza ezinhlelweni zokumaketha ezihambisanayo, okusho ukuthi singathola amakhomishini akhokhelwayo okuthenga ngezixhumanisi zamawebhusayithi abathengisi.
Isikhathi sokuthumela: Feb-25-2021